Sage Journals: Discover world-class research

Abstract

Keywords

Enterovirus rituximab neuromyelitis optica spectrum disorder multiple sclerosis

Get full access to this article

View all access options for this article.

References

Luciani

Ninove

Zandotti

, et al. Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease. Mult Scler J 2021; 27: 320–323.

Pruitt

AA.

Nervous system viral infections in immunocompromised hosts. Handb Clin Neurol 2014; 123: 685–704.

Kassab

Saghi

Boyer

, et al. Fatal case of enterovirus 71 infection and rituximab therapy, France, 2012. Emerg Infect Dis 2013; 19(8): 1345–1347.

Ahmed

Buckland

Davies

, et al. Enterovirus 71 meningoencephalitis complicating rituximab therapy. J Neurol Sci 2011; 305: 149–151.

Whittam

Tallantyre

Jolles

, et al. Rituximab in neurological disease: Principles, evidence and practice. Pract Neurol 2019; 19(1): 5–20.

Cohen

Romero

Bas

, et al. Monitoring CD27+ memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: Results from a bicentric study. J Neurol Sci 2017; 373: 335–338.

Uncovering the underhanded: B-cell depletion therapies and severe viral infections – Commentary on ‘Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease’

Abstract

Keywords

Get full access to this article

References